|
|
Reviews |
| How can oncogenic transcription factors cause cancer: a critical review of the myb story |
1301 |
| M Introna & J Golay
|
|
Abstract
Full Article (PDF)
|
|
| Hematopoietic, immunomodulatory and epithelial effects of interleukin-11 |
1307 |
| US Schwertschlag,
WL Trepicchio,
KH Dykstra,
JC Keith,
KJ Turner & AJ Dorner
|
|
Abstract
Full Article (PDF)
|
|
Original Manuscripts |
| From Bench to Therapy |
| Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy |
1316 |
| H Kosugi,
M Towatari,
S Hatano,
K Kitamura,
H Kiyoi,
T Kinoshita,
M Tanimoto,
T Murate,
K Kawashima,
H Saito & T Naoe
|
|
Abstract
Full Article (PDF)
|
|
| Clinical Laboratory Correlates, Clinical-cytogenetics correlates |
| Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia |
1325 |
| SD Raynaud,
N Dastugue,
D Zoccola,
SA Shurtleff,
S Mathew & SC Raimondi
|
|
Abstract
Full Article (PDF)
|
|
| Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia |
1331 |
| S Stilgenbauer,
L Bullinger,
A Benner,
K Wildenberger,
M Bentz,
K Döhner,
AD Ho,
P Lichter & H Döhner
|
|
Abstract
Full Article (PDF)
|
|
| Clinical-cyclins D correlates |
| Selective usage of D-type cyclins in lymphoid malignancies |
1335 |
| R Suzuki,
H Kuroda,
H Komatsu,
Y Hosokawa,
Y Kagami,
M Ogura,
S Nakamura,
Y Kodera,
Y Morishima,
R Ueda & M Seto
|
|
Abstract
Full Article (PDF)
|
|
| Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder |
1343 |
| V Levy,
V Ugo,
A Delmer,
R Tang,
S Ramond,
JY Perrot,
R Vrhovac,
JP Marie,
R Zittoun & F Ajchenbaum-Cymbalista
|
|
Abstract
Full Article (PDF)
|
|
| Clinical-immunophenotype-oncogenes correlates |
| Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK) |
1352 |
| C Rochlitz,
A Lohri,
M Bacchi,
M Schmidt,
S Nagel,
M Fopp,
MF Fey,
R Herrmann & A Neubauer
|
|
Abstract
Full Article (PDF)
|
|
| Molecular Cytogenetics |
Activation of EVI1 transcripts with chromosomal translocation joining the TCRV locus and the EVI1 gene in human acute undifferentiated leukemia cell line (Kasumi-3) with a complex translocation of der(3)t(3;7;8) |
1359 |
| K Suzukawa,
T Kodera,
S Shimizu,
T Nagasawa,
H Asou,
N Kamada,
M Taniwaki,
J Yokota & K Morishita
|
|
Abstract
Full Article (PDF)
|
|
| Frequent allelic loss of the RB, D13S319 and D13S25 locus in myeloid malignancies with deletion/translocation at 13q14 of chromosome 13, but not in lymphoid malignancies |
1367 |
| K Tanaka,
M Arif,
M Eguchi,
SX Guo,
Y Hayashi,
H Asaoku,
T Kyo,
H Dohy & N Kamada
|
|
Abstract
Full Article (PDF)
|
|
| FLT3 Biology |
| SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor |
1374 |
| S Marchetto,
E Fournier,
N Beslu,
T Aurran-Schleinitz,
P Dubreuil,
J-P Borg,
D Birnbaum & O Rosnet
|
|
Abstract
Full Article (PDF)
|
|
| Minimal Residual Disease in CML |
| Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation |
1383 |
| M Eder,
K Battmer,
S Kafert,
A Stucki,
A Ganser & B Hertenstein
|
|
Abstract
Full Article (PDF)
|
|
| Sensitivity and Resistance to Therapy |
| Idarubicin DNA intercalation is reduced by MRP1 and not Pgp |
1390 |
| MEP Smeets,
RAP Raymakers,
G Vierwinden,
AHM Pennings,
J Boezeman,
H Minderman & TM de Witte
|
|
Abstract
Full Article (PDF)
|
|
| Apoptosis |
| Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome in blastic transformation |
1399 |
| J Nishimaki,
K Miyazawa,
M Yaguchi,
T Katagiri,
Y Kawanishi,
K Toyama,
K Ohyashiki,
S Hashimoto,
K Nakaya & T Takiguchi
|
|
Abstract
Full Article (PDF)
|
|
| APL |
| Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - the occurrence of retinoic acid syndrome is a risk factor |
1406 |
| B-S Ko,
J-L Tang,
Y-C Chen,
M Yao,
C-H Wang,
M-C Shen & H-F Tien
|
|
Abstract
Full Article (PDF)
|
|
| Normal Hemopoiesis and Stemcellology |
| CD34high+CD38low/- cells generated in a xenogenic coculture system are capable of both long-term hematopoiesis and multiple differentiation |
1409 |
| T Tsuji,
K Itoh,
Y Nishimura-Morita,
Y Watanabe,
D Hirano,
KJ Mori & K Yatsunami
|
|
Abstract
Full Article (PDF)
|
|
| Biology of Phagocytes |
| Cytosine demethylation of the proteinase-3/myeloblastin primary granule protease gene during phagocyte development |
1420 |
| M Lübbert,
A Tobler & M Daskalakis
|
|
Abstract
Full Article (PDF)
|
|
| Lymphomas |
| Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin’s lymphoma |
1428 |
| M-C Jacob,
S Agrawal,
L Chaperot,
C Giroux,
R Gressin,
F Le Marc’Hadour,
M Favre,
J-J Sotto,
J-C Bensa & J Plumas
|
|
Abstract
Full Article (PDF)
|
|
| A high serum soluble Fas/APO-1 level is associated with a poor outcome of aggressive non-Hodgkin’s lymphoma |
1434 |
| N Niitsu,
K Sasaki & M Umeda
|
|
Abstract
Full Article (PDF)
|
|
| Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes |
1441 |
| S Harada,
R Suzuki,
K Uehira,
Y Yatabe,
Y Kagami,
M Ogura,
H Suzuki,
A Oyama,
Y Kodera,
R Ueda,
Y Morishima,
S Nakamura & M Seto
|
|
Abstract
Full Article (PDF)
|
|
| CD44 expression predicts disease outcome in localized large B cell lymphoma |
1448 |
| P Drillenburg,
VJM Wielenga,
MHH Kramer,
JHJM van Krieken,
HC Kluin-Nelemans,
J Hermans,
S Heisterkamp,
EM Noordijk,
PM Kluin & ST Pals
|
|
Abstract
Full Article (PDF)
|
|
Biotechnical Methods Section (BTS) |
| Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions |
1456 |
| C Tarella,
P Corradini,
M Astolfi,
P Bondesan,
D Caracciolo,
C Cherasco,
M Ladetto,
F Giaretta,
I Ricca,
U Vitolo,
A Pileri & D Ferrero
|
|
Abstract
Full Article (PDF)
|
|
Correspondence |
| Concamitant expression of the rare E1/A3 and B2/A3 types of BCR/ABL transcript in a chronic myeloid leukemia (CML) patient |
1463 |
| G Martinelli,
M Amabile,
C Terragna,
N Testoni,
E Ottaviani,
V Montefusco,
A de Vivo,
M Baccarani,
P Ricci,
G Saglio & S Tura
|
|
Full Article (PDF)
|
|
| Absence of Kaposi’s sarcoma-associated herpesvirus (KSHV) in bone marrow cells from Japanese myeloma patients |
1465 |
| N Harada,
H Hata,
F Matsuno,
T Sonoki,
N Kuribayashi,
H Matsuzaki & H Mitsuya
|
|
Full Article (PDF)
|
|
| Philadelphia chromosome-positive cells are equally distributed in AC133+ and AC133- fractions of CD34+ peripheral blood progenitor cells from patients with CML |
1466 |
| CF Waller,
UM Martens & W Lange
|
|
Full Article (PDF)
|
|
| P-glycoprotein expression is associated with resistance to spontaneous in vitro apoptosis in AML |
1468 |
| M Pallis & N Russell
|
|
Full Article (PDF)
|
|
| TEL-AML1 positivity in relapsed B cell precursor acute lymphoblastic leukemia in childhood |
1469 |
| K Seeger,
D Buchwald,
T Taube,
A Peter,
A von Stackelberg,
G Schmitt,
J Köchling & G Henze for the Berlin-Franfurt-Münster Study Group
|
|
Full Article (PDF)
|
|
| Significance of the TEL-AML1 fusion gene in childhood AML |
1470 |
| JE Rubnitz,
JR Downing & C-H Pui
|
|
Full Article (PDF)
|
|
| Megakaryocyte growth factors and acute myeloid leukemia |
1471 |
| K Kushansky
|
|
Full Article (PDF)
|
|
| Clinical use of thrombopoietin |
1471 |
| OG Ottmann,
D Hoelzer & WK Hofmann
|
|
Full Article (PDF)
|
|
